Hybrid Alginate–Graphene Composites: Biochemical Features and Biomedical Potential
Marine Drugs · 09.08.2025 · 23 (8) · 323
DOI: 10.3390/md23080323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 09.08.2025. Verfasst von Marcin H Kudzin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Łukasiewicz Research Network, Lodz Institute of Technology, 19/27 Marii Sklodowskiej-Curie Str., 90-570 Lodz, Poland. Hauptthemen laut MEDLINE: Graphite, Alginates, Biocompatible Materials. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alginate-based materials are widely studied for biomedical use, but their limited mechanical properties and variable biocompatibility pose challenges. In this work, hybrid composites composed of alginate, calcium, and graphene oxide were fabricated using a freeze-drying method and cross-linked with calcium ions via calcium chloride at different concentrations. Structural and morphological features were assessed using SEM, EDS, ICP-MS, and BET analysis. The resulting composites exhibited a porous architecture, with calcium incorporation confirmed by elemental analysis. Surface characteristics and pore parameters were influenced by the presence of graphene oxide and the cross-linking process. The effects of the materials on haemostasis were evaluated through activated partial thromboplastin time (aPTT) and prothrombin time (PT) assays, revealing modulation of the intrinsic coagulation pathway without significant changes in the extrinsic pathway. In this study, we analysed the effect of alginate–graphene oxide composites on the viability of peripheral blood mononuclear (PBM) cells and human foreskin fibroblasts from the Hs68 cell line. We also assessed the genotoxic potential of alginate–graphene oxide composites on these cells. Our results showed no cyto- or genotoxic effects of the material on either cell type. These findings suggest the biocompatibility and safe character of alginate–graphene oxide composites for use with blood and skin cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Łukasiewicz Research Network, Lodz Institute of Technology, 19/27 Marii Sklodowskiej-Curie Str., 90-570 Lodz, Poland.
- Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
ORCID-Profile: Marcin H Kudzin, Anna Kaczmarek, Cesar Hernandez, Klaudia Piekarska, Katarzyna Woźniak
Zitieren
APA
Kudzin, M. H., Kaczmarek, A., Mrozińska, Z., Hernandez, C., Piekarska, K., Woźniak, K., Juszczak, M., & Król, P. (2025). Hybrid Alginate–Graphene Composites: Biochemical Features and Biomedical Potential. Marine Drugs, 23(8), 323. https://doi.org/10.3390/md23080323
Vancouver
Kudzin MH, Kaczmarek A, Mrozińska Z, Hernandez C, Piekarska K, Woźniak K, et al. Hybrid Alginate–Graphene Composites: Biochemical Features and Biomedical Potential. Marine Drugs. 2025;23(8):323. doi:10.3390/md23080323
BibTeX
@article{Kudzin2025,
author = {Kudzin, Marcin H and Kaczmarek, Anna and Mrozińska, Zdzisława and Hernandez, Cesar and Piekarska, Klaudia and Woźniak, Katarzyna and Juszczak, Michał and Król, Paulina},
title = {Hybrid Alginate–Graphene Composites: Biochemical Features and Biomedical Potential},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {8},
pages = {323},
doi = {10.3390/md23080323}
}
EUVIMED